Docosapentaenoic acid (22:5, n-3), an elongation metabolite of eicosapentaenoic acid (20:5, n-3), is a potent stimulator of endothelial cell migration on pretreatment in vitro
about
Omega-3 Fatty Acids and Skeletal Muscle HealthA review of the biologic and pharmacologic role of docosapentaenoic acid n-3Dietary sources, current intakes, and nutritional role of omega-3 docosapentaenoic acid.Dietary n-6 polyunsaturated fatty acid deprivation increases docosahexaenoic acid metabolism in rat brain.Does nutrition have a role in peripheral vascular disease?Omega-3 fatty acids modulate Weibel-Palade body degranulation and actin cytoskeleton rearrangement in PMA-stimulated human umbilical vein endothelial cells.LC/ESR/MS study of pH-dependent radical generation from 15-LOX-catalyzed DPA peroxidation.Divergent shifts in lipid mediator profile following supplementation with n-3 docosapentaenoic acid and eicosapentaenoic acidEndothelial cell prostacyclin synthesis induced by lymphocytes is independent of the membrane fatty acid composition of both cell types and of E-selectin, VCAM-1 or ICAM-1-mediated adhesion.Eicosapentaenoic acid inhibits endothelial cell migration in vitroLipid remodelling and an altered membrane proteome may drive the effects of EPA and DHA treatment on skeletal muscle glucose uptake and protein accretion.Attenuation of ciclosporin-induced nephrotoxicity by dietary supplementation of seal oil in Sprague-Dawley rats.Fads3 modulates docosahexaenoic acid in liver and brain.Vitro culture of axe-head glochidia in pink heelsplitter Potamilus alatus and mechanism of its high host specialists.Elongation of eicosapentaenoyl-CoA to docosapentaenoyl-CoASystematic Analysis of Fatty Acids in Human Cells with a Multiplexed Isobaric Tag (TMT)-Based Method.Effect of different sources of dietary omega-3 fatty acids on general performance and fatty acid profiles of thigh, breast, liver and portal blood of broilers
P2860
Q28084892-961A5315-DAE5-4321-BE68-526AA614F8A8Q28248251-9DC323F0-CC47-4612-B51A-A6674EC9A5E9Q35742951-AE30115B-44F8-4520-93E1-81D34934B954Q35812881-7BAECF54-FED7-4178-981A-C98533EE05D8Q36392251-4CC87259-49EA-4B42-9945-6DBF67442FFDQ37369813-16507071-9587-4EF3-B327-046809852588Q38270838-3838F952-7037-4EF7-8F10-E41C1EA269E9Q39556645-53E22C47-9BC3-419F-A484-6B68273C7A33Q42505034-A0362527-8614-4BCC-8B85-5DAC6C3D4803Q42591178-314D7804-A11A-4D60-B2DF-C5FCD41F38E0Q46343646-88B9B8C3-DC9C-4094-BBAB-A6368EE22534Q46783266-C0AF15C1-7F3E-4BEA-B907-27D9D523B3C8Q48141298-2A6BE52B-6903-45EE-8504-FD8AD613206FQ49980301-6B7C192E-3E35-40B9-9503-D356745E4F63Q50293586-73D33D18-B50D-4C84-84B0-DB5A096AF932Q52361886-4BDFEFAD-D21B-448C-AD88-7720B2B00BEAQ57588570-DFAF27BD-9C79-4541-8471-E58EC33789B0
P2860
Docosapentaenoic acid (22:5, n-3), an elongation metabolite of eicosapentaenoic acid (20:5, n-3), is a potent stimulator of endothelial cell migration on pretreatment in vitro
description
1996 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի մայիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1996
@ast
im Mai 1996 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1996/05/01)
@sk
vědecký článek publikovaný v roce 1996
@cs
wetenschappelijk artikel (gepubliceerd op 1996/05/01)
@nl
наукова стаття, опублікована в травні 1996
@uk
مقالة علمية (نشرت في مايو 1996)
@ar
name
Docosapentaenoic acid (22:5, n ...... ation on pretreatment in vitro
@ast
Docosapentaenoic acid (22:5, n ...... ation on pretreatment in vitro
@en
Docosapentaenoic acid (22:5, n ...... ation on pretreatment in vitro
@nl
type
label
Docosapentaenoic acid (22:5, n ...... ation on pretreatment in vitro
@ast
Docosapentaenoic acid (22:5, n ...... ation on pretreatment in vitro
@en
Docosapentaenoic acid (22:5, n ...... ation on pretreatment in vitro
@nl
prefLabel
Docosapentaenoic acid (22:5, n ...... ation on pretreatment in vitro
@ast
Docosapentaenoic acid (22:5, n ...... ation on pretreatment in vitro
@en
Docosapentaenoic acid (22:5, n ...... ation on pretreatment in vitro
@nl
P2093
P1476
Docosapentaenoic acid (22:5, n ...... ation on pretreatment in vitro
@en
P2093
T. Kanayasu-Toyoda
P304
P356
10.1016/S0952-3278(96)90045-9
P577
1996-05-01T00:00:00Z